Zebrafish as an emerging tool for drug discovery and development for thyroid diseases.
Zebrafish is a useful model for understanding human genetics and diseases and has evolved into a prominent scientific research model.
APA
Yadav P, Sarode LP, et al. (2022). Zebrafish as an emerging tool for drug discovery and development for thyroid diseases.. Fish & shellfish immunology, 130, 53-60. https://doi.org/10.1016/j.fsi.2022.09.001
MLA
Yadav P, et al.. "Zebrafish as an emerging tool for drug discovery and development for thyroid diseases.." Fish & shellfish immunology, vol. 130, 2022, pp. 53-60.
PMID
36084888
Abstract
Zebrafish is a useful model for understanding human genetics and diseases and has evolved into a prominent scientific research model. The genetic structure of zebrafish is 70% identical to that of humans. Its small size, low cost, and transparent embryo make it a valuable tool in experimentation. Zebrafish and mammals possess the same molecular mechanism of thyroid organogenesis and development. Thus, thyroid hormone signaling, embryonic development, thyroid-related disorders, and novel genes involved in early thyroid development can all be studied using zebrafish as a model. Here in this review, we emphasize the evolving role of zebrafish as a possible tool for studying the thyroid gland in the context of physiology and pathology. The transcription factors nkx2.1a, pax2a, and hhex which contribute a pivotal role in the differentiation of thyroid primordium are discussed. Further, we have described the role of zebrafish as a model for thyroid cancer, evaluation of defects in thyroid hormone transport, thyroid hormone (TH) metabolism, and as a screening tool to study thyrotoxins. Hence, the present review highlights the role of zebrafish as a novel approach to understand thyroid development and organogenesis.
MeSH Terms
Animals; Disease Models, Animal; Drug Discovery; Gene Expression Regulation, Developmental; Humans; Thyroid Diseases; Thyroid Hormones; Transcription Factors; Zebrafish
같은 제1저자의 인용 많은 논문 (3)
- In-Silico Identification of Natural Compounds as Dual Inhibitors of Aromatase and CDK4/6: A Multi-Target Approach for ER-Positive Breast Cancer Treatment.
- Robotic approach to pediatric augmentation cystoplasty: Feasibility, long-term outcomes, and technical refinements.
- Gefitinib-induced unilateral papulopustular dermatosis: an uncommon presentation.